Sertraline and Danaparoid: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordDanaparoid
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Taking sertraline and danaparoid together can raise your risk of bleeding. Sertraline is an antidepressant (an SSRI), and one thing it does as a side effect is make your platelets (the cells that help your blood clot) a little less able to do their job. Danaparoid is a blood thinner. Put them together and both are working against clotting at the same time, so bruises, nosebleeds, or bleeding may happen more easily.
Please don't stop either medicine on your own. Both were prescribed for good reasons. Just watch for easy bruising, nosebleeds, or unusual bleeding, and let your pharmacist or doctor know. Your care team can keep an eye on you and adjust things if needed.
Effect: Additive increased bleeding risk (pharmacodynamic, not a prodrug interaction).
- Mechanism: SSRIs like sertraline deplete platelet serotonin, impairing platelet-mediated hemostasis; danaparoid provides anticoagulant (anti-Xa) effect. Effects are additive on hemostasis.
- Direction/magnitude: Enhanced bleeding tendency; supported by case-control and cohort data (SSRI plus anticoagulant).
- Onset: Delayed. Evidence: Probable.
- Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and signs of major hemorrhage. Counsel patient on bleeding precautions. Dose/therapy may be individualized by the care team; consider closer monitoring during concurrent use.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients that their bleeding risk is elevated.1. Hemostasis depends in part on the release of serotonin from platelets. Studies of both case-control and cohort design have demonstrated that taking SSRIs (sertraline among them) alongside anticoagulants correlates with a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant can amplify the likelihood of bleeding. Among the reported bleeding events are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that threaten life 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
The good news: your care team can manage this safely. Keep taking both medicines exactly as prescribed unless your doctor or pharmacist tells you otherwise.
- Watch for warning signs: nosebleeds, easy bruising, small red spots on the skin, blood in urine or stool, black stools, or bleeding that won't stop.
- Report any unusual bleeding to your pharmacist or prescriber promptly.
- Your team may monitor you more closely while you use these two together, and your therapy can be individualized if needed.
- Tell any provider or dentist you are on both a blood thinner and an SSRI before procedures.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported an elevated risk of clinically relevant bleeding (defined as hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while concurrently on SSRI therapy or within 2 weeks after stopping an SSRI. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched with randomly chosen patients who received warfarin alone (n=117). The SSRIs used were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group 10 patients had 14 bleeds over 586.4 treatment years. The associated overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years, respectively. The hazard ratio for a first bleed during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. In patients who bled during concurrent administration, the SSRIs involved were sertraline or citalopram. Adding an SSRI did not produce a change in warfarin dose or INR (p=0.48 and p=0.31, respectively). Study findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) found an increased risk of hospitalization due to non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients taking SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial of 12 healthy volunteers, researchers evaluated sertraline's effect on the plasma protein binding of warfarin. On days 1 and 32 of the study, all participants received warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either sertraline or placebo; the sertraline dose was progressively raised from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially during the month before delivery, has been linked with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Danaparoid together?
Sertraline and danaparoid together can add up to a higher bleeding risk, so watch for unusual bruising or bleeding and report it to your care team. Don't stop either medicine on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Danaparoid interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Danaparoid interaction managed?
The good news: your care team can manage this safely. Keep taking both medicines exactly as prescribed unless your doctor or pharmacist tells you otherwise. Watch for warning signs: nosebleeds, easy bruising, small red spots on the skin, blood in urine or stool, black stools, or bleeding that won't stop. Report any unusual bleeding to your pharmacist or prescriber promptly. Your team may monitor y… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Danaparoid need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Danaparoid
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist